Delayed cardiac toxicity from anthracycline therapy

Pediatrician. 1991;18(1):49-52.


Survivors of childhood cancer who received anthracycline treatment have a high incidence of abnormal cardiac function. Cardiac decompensation and death can appear many years after completion of chemotherapy. These survivors require periodic evaluation of cardiac function and rhythm.

MeSH terms

  • Arrhythmias, Cardiac / chemically induced*
  • Child
  • Daunorubicin / adverse effects*
  • Doxorubicin / adverse effects*
  • Follow-Up Studies
  • Heart / drug effects*
  • Heart Failure / chemically induced*
  • Humans
  • Neoplasms / drug therapy


  • Doxorubicin
  • Daunorubicin